{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "16571-856",
      "generic_name": "Pentoxifylline",
      "labeler_name": "Rising Pharma Holdings, Inc.",
      "brand_name": "Pentoxifylline",
      "active_ingredients": [
        {
          "name": "PENTOXIFYLLINE",
          "strength": "400 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "16571-856-01",
          "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)",
          "marketing_start_date": "20260605",
          "sample": false
        },
        {
          "package_ndc": "16571-856-05",
          "description": "50 BLISTER PACK in 1 CARTON (16571-856-05)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20260605",
          "sample": false
        },
        {
          "package_ndc": "16571-856-11",
          "description": "10 BLISTER PACK in 1 CARTON (16571-856-11)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20260605",
          "sample": false
        },
        {
          "package_ndc": "16571-856-50",
          "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)",
          "marketing_start_date": "20260605",
          "sample": false
        },
        {
          "package_ndc": "16571-856-90",
          "description": "1 BLISTER PACK in 1 CARTON (16571-856-90)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20260605",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Rising Pharma Holdings, Inc."
        ],
        "rxcui": [
          "312301"
        ],
        "spl_set_id": [
          "cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0316571856503"
        ],
        "nui": [
          "N0000175895",
          "N0000009065"
        ],
        "pharm_class_epc": [
          "Blood Viscosity Reducer [EPC]"
        ],
        "pharm_class_pe": [
          "Hematologic Activity Alteration [PE]"
        ],
        "unii": [
          "SD6QCT3TSU"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "465e591b-4af7-4b59-a076-73bc26758eda",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240611",
      "product_id": "16571-856_465e591b-4af7-4b59-a076-73bc26758eda",
      "application_number": "ANDA074425",
      "brand_name_base": "Pentoxifylline",
      "pharm_class": [
        "Blood Viscosity Reducer [EPC]",
        "Hematologic Activity Alteration [PE]"
      ]
    }
  ]
}